MEDICAL RESOURCES

Tepotinib c-Met kinase inhibitor

Status

• Tepotinib (also known as MSC2156119J) is an investigational small molecule inhibitor of the c-Met receptor tyrosine kinase

• Alterations in the c-Met signaling pathway are found in various cancer types and appear to correlate with aggressive tumor behavior and poor clinical prognosis

‡Tepotinib is the recommended international nonproprietary name(INN) for the c-Met kinase inhibitor (MSC2156119J).
Action SVG
Action SVG
Action SVG